Life Sciences 360 is an interview show that educates anyone on challenges, trends, and insights in the life-sciences industry. Hosted by Harsh Thakkar, a life-sciences industry veteran and CEO and co-founder of Qualtivate, the show features subject-matter experts, business leaders, and key life-science partners contributing to bringing new therapies to patients worldwide. Harsh is passionate about advancements in life sciences and tech and is always eager to learn from his guests— making the ...
…
continue reading
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
…
continue reading
Students and scholars in life sciences need to use many skills to survive and excel during scientific training, which involves listening, reading, writing, and speaking. But I have seen many of them struggle in understanding and learning those skills. As a professor, I will guide you through the skills, so that you will learn and improve successfully in your professional life. Please visit my website for more information (https://synaptologica.com/), and send me emails with questions, commen ...
…
continue reading
Join us as we tackle the essential factors that drive successful commercial products. Our team interviews industry thought leaders to explore regulatory compliance, market trends, and innovation. Stay ahead in this dynamic industry.
…
continue reading
The lastest news in AI and Life Sciences
…
continue reading
Life sciences knowledge center
…
continue reading
Helping people understand the latest emerging Life Sciences Trends without the jargon
…
continue reading
Internal launch of the life sciences initiative
…
continue reading
Join Štěpán Hýsek as he hosts interviews about exciting research projects across various life sciences fields. 'SHowcase for life sciences' is a place where researchers themselves present findings of their cutting-edge research.
…
continue reading
With a bird’s-eye-view of the life sciences industry, Life Sciences Pennsylvania President & CEO, Chris Molineaux, joins Rachael Bushey, Partner and Co-managing Partner of the Philadelphia office of Goodwin Procter to welcome life sciences leaders to give insights into the complex and high-risk world of pharmaceuticals, biotechnology, medical devices, diagnostics and the services that support them. Here we learn what it means to be a life sciences leader.
…
continue reading
BDO’s Health & Life Sciences Rx Podcast, hosted by The BDO Center for Healthcare Excellence & Innovation and the Life Sciences practice, seeks to provide insights into the trends disrupting healthcare and how companies can adapt and evolve in an ever-changing business landscape.
…
continue reading
Invent: Life Sciences, is a podcast exploring the impact of biology and technology on the life sciences sector. Each week, we're joined by the top scientists, engineers, and academics working at the vanguard of this vital industry, to give you a behind-the-scenes look at the world of the life sciences.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Mathematical, Physical and Life Sciences at the Department for Continuing Education
Oxford University
A collection of audio and video resources of lectures, seminars and presentations from the Department's mathematical, physical and life sciences programmes.
…
continue reading
In this limited podcast series, we’ve brought together a series of conversations with experts from medical science to finance to help demystify investing in biotech, medtech and digital health (also known as the life sciences). This podcast has been brought to you by Life Sciences WA (Western Australia’s Life Sciences Industry Association) in collaboration with Talking HealthTech. It has been possible with funding support from the West Australian government through the New Industries Fund an ...
…
continue reading
The podcast that gives you slices from the life sciences companies revolutionizing the industry. Produced by Slice of Media, Inc.
…
continue reading
Leading Minds podcast by Life Sciences Voice delves deep inside the minds of the top life sciences executives, including pharmaceuticals, biotech, medical devices, consumer health, animal health, and leaders from related industries. In every episode, we meet a leader who has made a lasting impact in the life sciences industry and continues to drive the industry forward. We go beyond the name and the title to unravel their personality, their beliefs, their mission, and most importantly, to un ...
…
continue reading
The Stephenson Harwood life sciences podcast provides an overview of key legal developments relating to the sector.
…
continue reading
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
…
continue reading
Join us on this podcast series as we meet the icons of the biotechnology industry, exploring the current state of innovation in Queensland and what the future holds for our best and brightest. Hosted by Anthony Frangi, each episode will feature a new guest sharing their unique angle on the capabilities of the industry in Queensland.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Image Movie Bachelor und Master in Life Sciences | Video
FHNW | HSL | Hochschule für Life Sciences-HSL
Life Sciences tönen nicht nur spannend, sondern sind es auch! Wir messen uns in Lehre und Forschung an internationalen Qualitätsstandards und fördern Transdisziplinarität sowie die Kooperation mit Netzwerken und vielfältigen Partnern. Unser Ziel ist es, den faszinierenden Life Sciences-Wissenschaften marktwirtschaftliche Anwendungen zu geben und gemeinsam mit Forschungspartnern ein international unverwechselbares Hochschulprofil zu etablieren. Im Zentrum unserer Aus- und Weiterbildung steht ...
…
continue reading
Join Nancy Donohoo’s bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy’s guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innov ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
32. Is it important to include positive and negative controls in each experiment? Lesson from Nobel Laureates' work (mini-series: reading-22)
21:32
21:32
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
21:32
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Why the Top 1% are lonely- insights from Dr. Robyn Odegaard
36:17
36:17
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
36:17
Welcome to episode 060 of Life Sciences 360. In this episode of Life Sciences 360, host Harsh Thakkar sits down with Dr. Robin Odegaard, a high-performance business psychologist and professional confidant, to discuss the hidden struggles that come with success. They dive deep into topics like imposter syndrome, self-sabotage, complex priorities, an…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Swimming in the Deep End of AI
59:08
59:08
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
59:08
Brendan Frey, founder and chief innovation officer of Deep Genomics, sits down with Amar Drawid to discuss how the company is using deep learning to leverage massive RNA biology datasets to drive the development of new therapies.Kirjoittanut Levine Media Group
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Balancing Claims and Compliance in Healthcare Marketing, with Group 31 CEO Crystal Weber
29:20
29:20
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
29:20
Creating labeling claims that support business goals without getting into compliance issues can be a tough sea to navigate. Today, join Kymanox Director of Regulatory Affairs Stefanie Johns as she sits down with Crystal Weber, CEO of Group 31, in this episode on The Factor, to discuss the complexities of marketing in the highly regulated healthcare…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
31. Is it OK to say, “I don’t know” in response to technical questions? (Q&A-1: interview)
12:02
12:02
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
12:02
The first Q&A session! Question of today: Is it OK to say, “I don’t know” in response to technical questions in an interview when you apply for a life-science research position in a laboratory? I will give you my answer and the reasons why. Disclaimer: What I'm going to tell you is my personal opinion. It is possible that it does not apply to you i…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Science Behind Tome’s Programmable Genomic Integration Technology with CSO John Finn
43:30
43:30
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
43:30
Welcome to episode 059 of Life Sciences 360. In this episode of Life Sciences 360, Harsh Thakkar is joined by John Finn, Chief Scientific Officer at Tome Biosciences. John shares his inspiring journey of overcoming challenges, like his stutter, while making groundbreaking strides in gene therapy. They dive deep into Tome’s unique technology, PGI (P…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
30. Positive controls in another experiment by Nobel Laureates (mini-series: reading-21)
32:41
32:41
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
32:41
We will keep analyzing the specific positive controls that the Nobel Laureates used in their milestone article 1 that led to the Nobel Prize. We will examine the four positive controls in the third figure of this paper, and in other figures as well. Those positive controls did not necessarily show positive responses in multiple figures. We will obs…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inside the Lab: How Singota Solutions Leads in Early-Stage Pharma Development
32:25
32:25
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
32:25
Welcome to episode 058 of Life Sciences 360. In this insightful episode of Life Sciences 360, hosted by Harsh Thakkar, we explore the dynamic world of Contract Development and Manufacturing Organizations (CDMOs) with Ryan Memmer, Manager of Quality Control and Product Development at Singota Solutions. Ryan shares his journey from working at large p…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
29. Positive controls in experiments by Nobel Laureates (mini-series: reading-20)
25:31
25:31
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
25:31
Let’s analyze the specific positive controls that the Nobel Laureates used in their milestone article 1 that led to the Nobel Prize. We will look at the first two figures and four positive controls therein. As always, we are impressed by the meticulous design of the experiments by the Laureates. Here are the links to the Milestone Article 1 (Immuni…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bioidentical Hormone Replacement: A Deep Dive with Dr. Greg Brannon
38:19
38:19
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
38:19
Welcome to episode 057 of Life Sciences 360. In this special episode of Life Sciences 360, hosted by Harsh Thakkar, we dive into the fascinating world of bioidentical hormone replacement therapy (BHRT) with Dr. Greg Brannon, Medical Director and Founder of Optimalbio. Celebrating National Men's Health Education and Awareness Month, Dr. Brannon shar…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
28. Defining positive controls in life-science experiments (mini-series: reading-19)
13:11
13:11
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
13:11
In this episode, we shift our focus from negative controls to their counterparts: positive controls. We will begin by defining what we mean by positive controls. Then we will refine that definition to encourage practical and cautious thinking. Here are the links to the Milestone Article 1 (Immunity, 2005) by the Laureates, Dr. Katalin Karikó & Dr. …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How Green Elephant Biotech is making labs more sustainable with Joel Eichmann
38:36
38:36
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
38:36
Welcome to episode 056 of Life Sciences 360. Welcome to another episode of Life Sciences 360! In this episode, Harsh Thakkar is joined by Joel Eichmann, co-founder and managing director of Green Elephant Biotech. Green Elephant Biotech is a trailblazer in the biotech industry, focusing on sustainability and using plant-based materials to create inn…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Using AI to Make Biology Easier to Engineer
53:46
53:46
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
53:46
Ankit Gupta, the head of AI and Senior Director of Machine Learning Research for Ginkgo Bioworks sits down with Amar Drawid to discuss bioengineering beyond healthcare, how the company is using generative AI and large language models to accelerate bioengineering, it expects this to revolutionize the field.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
27. One-year anniversary: I started podcasting to help you (podcast update 5)
21:02
21:02
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
21:02
One-year anniversary of this podcast channel! Thank you for listening. Why did I start podcasting? The motivation or the trigger was the students’ feedback to my teaching and training: they loved it. My goal is to help you learn and polish your skills in life sciences. In this episode, I will talk about a little story of how I started podcasting. (…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Future of mRNA Therapies with Dr. Kate Broderick
34:16
34:16
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
34:16
Welcome to episode 055 of Life Sciences 360. In this episode of Life Sciences 360! In this episode, Harsh sits down with Dr. Kate Broderick, Chief Innovation Officer at Maravai Life Sciences. Dr. Broderick shares her journey from academia to leading innovation in the biotech industry, discusses the pivotal role of Clean Cap technology in COVID-19 v…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
26. Lessons learned from a failed experiment. Part 2 (mini-series: reading-18)
34:47
34:47
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
34:47
This episode continues from the last one. This will mark the end of our story about the life-science experiment that did not work at first, but worked well after extensive troubleshooting. We will talk about the remaining three lessons we can learn from the story. They will be about thoughtful approaches, and about probably the most important minds…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Vector Labs CEO Lisa Sellers on Innovation, Leadership, and Mentorship
42:57
42:57
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
42:57
Welcome to episode 054 of Life Sciences 360. In this episode of Life Science 360 ,Today, we are thrilled to have Lisa Sellers, the CEO of Vector Labs, as our special guest. Lisa shares her incredible journey from working at big names like Thermo Fisher and 10x Genomics to leading Vector Labs, a trusted manufacturer of reagents and critical componen…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Invisible Users: Applying Human Factors to Medical Device Servicing and Maintenance
33:43
33:43
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
33:43
Medical device design often focuses solely on clinical users, overlooking a crucial group: maintenance personnel. This oversight can lead to inefficient servicing, increased downtime, and potential safety risks. In this episode, we explore the importance of applying human factors principles to medical device maintenance and servicing. Our expert gu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
25. Lessons learned from a failed experiment. Part 1 (mini-series: reading-17)
31:30
31:30
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
31:30
In the last episode, we finished discussing details of the life-science experiments in our story. We observed that negative controls can be powerful tools for troubleshooting and ensuring data quality. The story gave us invaluable learning experience. What lessons can we learn? We will talk about three lessons related to negative controls today. Th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scientist on Epigenetic Tuning and Future Therapies at Tune Therapeutics
36:52
36:52
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
36:52
Welcome to episode 053 of Life Sciences 360. In this episode of Life Science 360, our host Harsh Thakkar sits down with Brian Cosgrove, Principal Scientist at Tune Therapeutics. Brian dives deep into the fascinating world of epigenetics and its role in developing therapies for complex diseases. He shares insights on how Tune Therapeutics is leverag…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
24. Negative controls put the pieces together in troubleshooting experiments (mini-series: reading-16)
46:41
46:41
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
46:41
We will see how the experimenters implemented a good, troubleshooting idea into a protocol that appeared to be challenging at first. We are continuing to discuss the troubleshooting of a real, life-science experiment in our story. Sophisticated thought processes made the experiment possible in the end. This episode celebrates the power of well-desi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Breaking Down Barriers in Psychedelic Drug Development
42:22
42:22
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
42:22
Welcome to episode 052 of Life Sciences 360. In this episode, of Life Sciences as we dive into the fascinating world of psychedelic therapeutics with Dr. Sam Clark, the Chief Executive Officer of Terran Biosciences. Dr. Clark shares his journey of founding Terran Biosciences, motivated by the need for better treatment options for psychiatric and ne…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How AI ls Reshaping the Future of Healthcare
1:00:21
1:00:21
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:00:21
Subodha Kumar, professor of statistics, operations, and data science and the founding director of the Center for Business Analytics and Disruptive Technologies at Temple University’s Fox School of Business, sits down with Amar Drawid to discuss how AI will improve operational efficiency in healthcare, enable mass customization for patients, and fre…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
23. Refining a troubleshooting idea: the power of identifying unknowns (mini-series: reading-15)
25:11
25:11
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
25:11
We will discuss the fourth and final idea, for troubleshooting a real, life-science experiment in our story. This idea was based on the previous three ideas. Then the experimenters took an impressive step. They identified key unknowns about the experiment, and refined and updated their idea. The updated idea laid the foundation for designing the cr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
From Genes to Treatments: Howard McLeod on Precision Medicine
41:14
41:14
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
41:14
Welcome to episode 051 of Life Sciences 360. We welcome Howard McLeod, a distinguished expert in precision medicine and pharmacogenomics. Howard shares his profound journey into the world of personalized medicine, emphasizing the significant impact of individualized treatments on cancer patients. From groundbreaking gene discoveries to advising cut…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Tony Martignetti on Inspired Leadership, Flashpoints, and Divergent Thinking
42:25
42:25
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
42:25
Welcome to episode 050 of Life Sciences 360. In this episode, Harsh Thakkar chats with Tony Martignetti, a top leadership development voice on LinkedIn and an advisor to numerous tech and life sciences executives. Tony shares his insights on inspired leadership, the importance of investing in people, and how to unlock potential within teams. They a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
22. Negative controls unveil a hidden culprit in a problematic experiment (mini-series: reading-14)
14:39
14:39
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
14:39
We continue our deep exploration into negative controls and their importance in troubleshooting life-science experiments. We follow a real-life story of an experiment that yielded unexpected results. Through the third troubleshooting experiment utilizing negative controls, the experimenters finally uncovered the culprit. We discuss how negative con…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Secrets of Biopharma Tech Transfers: Lessons Learned and Best Practices
24:34
24:34
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
24:34
Biologic drug developers face a persistent challenge - executing successful tech transfers of their processes between sites and scales. These transfers are pivotal but extremely complex, prone to issues from changes in facilities, equipment, materials, and process nuances. Failed or delayed tech transfers can derail entire programs, costing compani…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI
1:03:58
1:03:58
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:03:58
Mati Gill, CEO of AION Labs, sits down with Amar Drawid to discuss how the AI venture studio works with its Big Pharma partners to define the biggest drug development hurdles the industry faces; and how it holds challenges to attract academics, entrepreneurs, and life sciences professionals with the best solutions to build new companies.…
…
continue reading
We will be happy to announce the launch of a new way to stay connected with the show - a FREE email newsletter! Sign up to get updates on upcoming episodes, behind-the-scenes insights, and more. Please join the community by sending an email to: ideas@synaptologica.com. (My email is active. But my website is under construction. Please wait for a whi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Understanding Drug Pricing and the Impact of the Inflation Reduction Act with Jesse Mendelsohn
39:21
39:21
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
39:21
Welcome to episode 049 of Life Sciences 360. In this episode of Life Sciences 360, host Harsh Thakkar welcomes Jesse Mendelsohn, Senior Vice President at Model N. Jesse delves into the intricacies of revenue optimization and compliance within the pharmaceutical industry. He shares insights on how Model N's platform aids pharmaceutical companies in …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Juan Fernando Hidalgo Cordero & Utilisation of Totora
21:27
21:27
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
21:27
Join this episode to learn more about the totora plant and the huge possibilities of its utilisation.Kirjoittanut Stepan Hysek
…
continue reading
This episode of 'AI in Life Sciences' presents exciting updates from the world of artificial intelligence and its game-changing applications in the Life Sciences sector. Pioneering the breakthroughs, in our first news item, Seven AI has garnered an impressive $36 million in initial funding. This considerable investment will bolster the tech company…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How DoseMeRx is Transforming Patient Care
33:21
33:21
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
33:21
Welcome to episode 048 of Life Sciences 360. In this episode, Sharmeen discuss the current one-size-fits-all approach in healthcare and the need for precision dosing. Sharmeen explains how DoseMe platform simplifies complex dosing methods at the bedside, benefiting both clinicians and patients. Sharmeen also touch on the integration with electronic…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Decoding the Immune System to Optimize Immunotherapies
1:00:59
1:00:59
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:00:59
Noam Solomon, co-founder and CEO of Immunai, sits down with Amar Drawid to discuss how the company is using machine learning to take a multi-omics approach to understanding the complexities of the immune system, how it is constructing an atlas of immune cells, and how it is leveraging this to develop the next generation of immunomodulatory drugs.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How InVision helps you make drug development decisions? #lifesciences
40:12
40:12
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
40:12
Welcome to episode 047 of Life Sciences 360. In this video, We discuss the importance of using AI in decision making in the life sciences industry. Ben highlight the need for evidence-based decision making and the challenges of finding relevant information in a sea of data. Ben introduce InVision, a platform that helps biotech and pharma companies …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How CTMC is Changing Medicine Manufacturing
37:09
37:09
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
37:09
Welcome to episode 046 of Life Sciences 360. On this episode, Harsh discuss the intersection of luck and preparation in finding opportunities, particularly in the field of cell therapy. Harsh share insights from his conversation with Dr. Jason Bock, founder and CEO of CTMC, about the advancements and challenges in autologous cell therapies. We delv…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AI in Life Sciences: Should You Follow This Trend?
41:58
41:58
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
41:58
Welcome to episode 045 of Life Sciences 360. On this episode, Nagesh Nama and his team at XLM talk on why Gen.AI is essential in the software test world and share examples of its use in various industries, particularly in life sciences and manufacturing. They address the challenges faced by companies in adopting AI and provide solutions for integra…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Aligning with the Right CMO
33:06
33:06
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
33:06
Today's episode is all about Contract Manufacturing Organization (CMO) selection. When organizations are considering a CMO, how do they find the right one for them? We're joined by two Kymanox executives, Ryan Doxey, Senior Director of Technical Services, and Jason Martin, Senior Director of CGXP Technical Services. They highlight the importance of…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bringing Precision Medicine to Mental Health with AI
58:21
58:21
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
58:21
Behavioral health is one area of medicine that has lagged in the move towards precision medicine, in part because of a lack of high-quality evidence to drive decision-making. Holmusk is working to change that by using AI and real-world data to transform mental health care. Eze Abosi, chief growth officer for Holmusk, sits down with Amar Drawid to d…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The NASA Scientist Who Changed Cancer Diagnostics Forever
37:52
37:52
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
37:52
Dr. Arnon Chait, CEO of Cleveland Diagnostics, discusses his transition from NASA to the healthcare innovation space and the development of cancer diagnostics. Dr. Chait emphasizes the importance of using diagnostic advancements to strike a balance between over-screening and under-treating, particularly in the workup of cancer after failed screenin…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
20. Detective work of troubleshooting a puzzling experiment: negative control as a guide (mini-series: reading-13)
23:20
23:20
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
23:20
We will experience the fascinating world of scientific troubleshooting. In this episode, we will revisit a life-science experiment where researchers aimed to see if a specific chemical compound could enhance a particular function in cultured cells. Their plan seemed straightforward - a pilot experiment with a positive control (active compound) and …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Milan Šernek & Bio-based Adhesives
29:23
29:23
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
29:23
Listen to the new episode about bio-based adhesives from liquified wood, lignin, and tannin. Prof. Milan Šernek introduces how they are produced and where these adhesives can be used.Kirjoittanut Stepan Hysek
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How On-Demand Cleanrooms Can Speed Up Drug Development
28:24
28:24
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
28:24
With the market estimated to reach $11.5 billion by 2028. Clean Rooms on Demand is providing flexible and cost-effective solutions for biotech and pharma companies. The benefits of using clean rooms on demand include avoiding the high capital outlay and ongoing operational expenses of building and maintaining their own facilities, as well as the fl…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Michael Bailey: Winning for Cancer Patients with Purpose and Perseverance
37:03
37:03
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
37:03
Join us for an insightful discussion with Michael Bailey, CEO of AVEO Oncology. Michael and Jasmeet delve into the realities of career growth, exploring both the triumphs and setbacks. Michael, a strong advocate for active listening, shares how this skill empowers leaders. He'll discuss the common pitfalls of aspiring leaders feeling pressure to cl…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine
4:35
"AI in Life Sciences" dives into the world where technology and biology intersect, providing expert insight and analysis on the latest trends, breakthroughs, and controversies. In this episode, we explore a potential bird flu threat in Midwestern milk, the innovative use of AI in tackling workforce shortages in healthcare, and impressive revenue gr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Power and Peril of Generative AI in Biopharma and Healthcare
52:25
52:25
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
52:25
Healthtech and AI Executive Advisor Christian Hein sits down with Amar Drawid to discuss the use of generative AI in the life sciences, its transformational potential, and the current challenges that need to be addressed.Kirjoittanut Levine Media Group
…
continue reading
AI in Life Sciences is a podcast that keeps a finger on the pulse of technological advancement within the healthcare and pharmaceutical fields. In this episode, we'll take a deep dive into Novartis AG's recent nomination of former Bristol Myers CEO Giovanni Caforio as incoming chair, examining what this could mean for the company's future amidst th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Beyond the Pill: When Medicine Meets Mindset with CEO, Will Hind
30:39
30:39
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
30:39
How can behavioral science optimize pharmaceutical practices? Episode 042: Will Hind, CEO of Alpharmaxim Healthcare Communications, discusses the challenges and opportunities in integrating behavioral science with pharma strategies. Find out how this can lead to better patient outcomes and more tailored healthcare solutions. ----- Links: *Will Hind…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Advancements in AI Healthcare: ABOUT and Edgility Merger, Scopio Labs' Breakthrough, Innovaccer's HXP Launch, and GE Healthcare's Ultrasound Systems
3:29
"AI in Life Sciences" explores the intersect of artificial intelligence (AI) and healthcare this week. We start with a discussion on the ABOUT Healthcare's merger with Edgility which it is hoped will usher in a new era of care orchestration solutions, utilizing AI and predictive analytics to optimize hospital operations and improve patient care. We…
…
continue reading